Search Results 1611-1620 of 17805 for Substance+dependence
This study will assess change in Crohn's Disease Activity Index (CDAI). Risankizumab is an investigational drug being developed for the treatment of Crohn's ...
D., director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA), will lead an online fireside chat about the ...
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
“They are dangerous. They could have adverse effects that the individual doesn't even know about.” That includes addiction or accidental overdose. So when is it ...
A Study Of Acute Stimulation For The Modulation Of Epileptic Events With A Closed-Loop Brain Interchange System In Drug Resistant Epilepsy. Rochester, Minn ...
Deep brain stimulation in drug addiction treatment: Research progress and perspective. Frontiers in Psychiatry. 2022; doi:10.3389/fpsyt.2022.858638. Medical ...
clinical trial at Mayo, researchers are examining if the drug can prevent COVID-19 patients from getting worse. ... and addiction and chemical dependency issues.
A genome-wide RNAi screen identifies multiple RSK-dependent regulators of call migration Genes Dev.. 2010; 2654-2665. PST-20511677. Home; Publications. Fuel ...
The PK part (how the body processes the drug) will enroll about 18 participants. All participants will take (Z)-endoxifen capsules daily. Twelve ...
And what we really want to do is individualize drug therapy, and the way we're trying to do that is to take advantage of genetic differences among people ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.